The MARCKSL1 expression was compared with classical prognosticators such as age, tumor diameter, grade, hormone receptor status, presence of tumor-infiltrating lymphocytes (TILs) and proliferation, with distant metastases free survival as the endpoint. Here, MARCKSL1 is linked to neoplasm.